Integration of antiretroviral therapy with tuberculosis treatment. - Wikidata - awgldk - TriplyDB

Integration of antiretroviral therapy with tuberculosis treatment.

Integration of antiretroviral therapy with tuberculosis treatment.

http://www.wikidata.org/entity/Q35600960

about

t-tests, non-parametric tests, and large studies--a paradox of statistical practice?Integrated therapy for HIV and tuberculosis HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide HIV treatment cascade in tuberculosis patients HIV and tuberculosis--science and implementation to turn the tide and reduce deaths The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomi Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review Modelling HIV and MTB co-infection including combined treatment strategies Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pipeline of drugs for related diseases: tuberculosis The 15th Bangkok International Symposium on HIV Medicine Community-Acquired Pneumonia in HIV-Positive Patients: an Update on Etiologies, Epidemiology and Management.Recent advances in tuberculosis: New drugs and treatment regimens.Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar Understanding pharmacokinetics to improve tuberculosis treatment outcome.The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Tuberculosis and HIV co-infection in children.The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.Tuberculosis in tropical areas and immigrants.Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia.Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.Update on opportunistic infections in the era of effective antiretroviral therapy Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011)Current approaches to tuberculosis in the United States.Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial

P2860

Q21261934-AFD400E0-4BCF-47EF-8D9F-1868AAF90A82 Q26749428-3A31715B-CEE6-4B02-9958-1BAC08DF394B Q26771348-526E0212-1DAB-40A2-8E52-ACC45C18825A Q26782208-FB3ECF11-EC37-496C-B8EB-29F4A80C0FB4 Q26824501-24E84296-F0E1-4524-A68C-E7FEE92ADA51 Q27014121-A225F4CA-6677-4C84-8AA8-97AA0D17B7A5 Q27303476-6AF3FEAB-A30B-4931-BF04-66AAC9802E61 Q28069032-78FCB410-B0BF-4E1B-B4EC-515F70795AD7 Q28088557-CFB0F62B-F502-4496-8A42-A92FDD69F660 Q28389802-EEFFF875-294B-4088-99F6-BB0101284D65 Q28484857-E6140FDC-CA7C-4E69-AEDF-CF09663583C9 Q28485357-2E717660-729C-4093-AE8F-A142F7FE0DEA Q28538952-01303754-9636-4B10-8A7F-DF8460C782F7 Q28547436-03EB00D8-B7FF-47C4-ADBF-B960388CE54E Q28818217-30E34EB3-7E4B-47D7-B019-9169341075CD Q29396779-DFF3B662-8D8F-46D4-80ED-9611568905F3 Q30238577-C5B2A8DF-5F95-4EDD-ABD3-EEF1E8A903E9 Q30360811-0CEEB206-6584-4D01-8758-87A0C8B0537A Q30383131-C8AB88CA-C298-4F3B-B405-569E0E9A7C64 Q30411703-5FE8EB09-FBCD-4ADE-9217-8FC201EFE12F Q30658709-666BA504-C3B7-4116-AFD6-0BA6E9D080A4 Q31106576-983A483D-AFBA-4E30-9D3C-3B2DAF747B6D Q33584656-1A22F430-F18C-4C43-A513-1BA773E561F0 Q33592322-F7ADD19A-2E54-433A-91A3-31EF290522FB Q33758612-8AC443C1-5F1D-448F-9141-A8B4B2E85C95 Q33775397-C9899E51-62F8-4355-B891-5A3535F07216 Q33778365-9A5D03CB-AA0F-426F-867F-7FFEAD16C350 Q33806776-A8E6BBD2-8A10-4988-855A-C38BF6946D41 Q33922724-881BEFD8-80BB-4ABF-82BF-0803CF69573E Q33926262-D93DD305-749C-4307-A88B-C1BC6EB39983 Q34005593-9156062D-91D9-4740-8A96-CBF71FD5D481 Q34024416-6815D0BE-C538-4939-BCA9-D506B079017F Q34057466-6F4705E6-D80D-4FB9-9B03-02433AC1BF1C Q34085853-0A2B6A9C-100D-42D0-AA0B-2C0E3B494857 Q34098274-04DAC016-08CB-469A-A525-C016358D74C6 Q34137755-5B6817C2-31DF-4111-B779-840341FE3ADD Q34169277-7DA61181-41EE-414D-9D0F-54DFCE85C111 Q34279727-1D35CA38-DFE8-4EDF-84EE-8E982C98BD69 Q34282914-2E74282C-9BA0-4ECE-99CF-9AFFEDB49A6F Q34288207-D62AFB53-10EB-4D7D-9E4A-11FC0A0D65D5

P2860

Integration of antiretroviral therapy with tuberculosis treatment.

http://www.wikidata.org/entity/Q35600960

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Integration of antiretroviral therapy with tuberculosis treatment.

@ast

Integration of antiretroviral therapy with tuberculosis treatment.

@en

type

label

Integration of antiretroviral therapy with tuberculosis treatment.

@ast

Integration of antiretroviral therapy with tuberculosis treatment.

@en

prefLabel

Integration of antiretroviral therapy with tuberculosis treatment.

@ast

Integration of antiretroviral therapy with tuberculosis treatment.

@en

P1433

Q35600960-D0A39F12-F056-4609-9484-4E70F3F470FB

P1476

Q35600960-B854D9FA-5CAD-447C-94A1-1F6E94F6AB54

P2093

Q35600960-069B2EC5-60FB-4027-9DBA-92DB05AF11A5

Q35600960-7F2480B8-EBB2-4464-8530-28F900CFD1F8

Q35600960-9CDA0383-7C5F-4E9A-9498-84559C0F1D23

Q35600960-D12D158A-FF30-4742-9913-3D2AA85ACFCC

Q35600960-F4A6B27B-DB5A-4772-8503-E03C9D5BC3ED

P2860

Q35600960-170F5DC7-A9C7-4EBD-8552-B5368836D18A

Q35600960-3A0B0F67-863A-4B1B-BD55-5EA72638D374

Q35600960-3A614847-E646-482D-99B8-C39B2B134306

Q35600960-56D351D5-C16B-4FF3-B0D7-6EB548C51EDA

Q35600960-64BF327E-6CB8-4459-8C28-DC5FA37A4C9F

Q35600960-9BC16172-0391-4C2D-8B37-149B6102E282

Q35600960-B3AFB180-FF3A-415E-AC5F-EB951FCB92CC

Q35600960-C4611F7C-D235-45D8-A694-96020F4B627D

Q35600960-E042C558-35FE-4622-9DF9-18BEE6917C44

Q35600960-E1B9AA40-F0D7-4409-96A0-8E78A0950C45

P304

Q35600960-003D0EF7-5926-44B6-AC56-0C395F8BD7D3

P31

Q35600960-88A10D07-5CBD-48B9-BD8B-3033D8376ACF

P356

Q35600960-755884E7-371E-446C-A455-3EF8A66DE6F4

P407

Q35600960-8963513A-00FD-40C1-BB97-AF158ABC2E71

P433

Q35600960-E7EB1987-4D4B-4EF8-A182-139C2C006919

P478

Q35600960-EBE53C33-4CB9-4DFE-9D3E-CC5FBB7C2A7F

P50

Q35600960-06D46583-0855-4602-9D14-761AB8608065

Q35600960-077809FC-1565-4ABB-AD7A-C2C2366EF583

Q35600960-30BBA4DE-CBBF-4332-B2C5-EEA6D929754C

Q35600960-4D4C8280-D07E-4DB0-85A8-B11C060CB943

Q35600960-66394613-380C-424B-A1E9-AF9F30BEA3D6

Q35600960-C3637C06-F02C-4085-A61C-89AC20246929

Q35600960-DF8666B7-F742-4C68-BEC7-FFC415A41924

Q35600960-E3DF0885-02BB-4667-939E-603324B3E7BF

Q35600960-EFF5D765-29DD-40E8-92A8-146D4027744B

P577

Q35600960-BC535033-5DEC-4066-8F99-895A624F8343

P698

Q35600960-058166C3-E58A-45C8-8DC2-06E33A06E43A

P921

Q35600960-2C5A7604-C874-4573-902F-E9A6040762AB

Q35600960-54AAD94C-C1B0-4446-B8AB-87712CBDA09F

P932

Q35600960-3996A5F7-FBAF-4455-A813-A89A9D2915D3

P356

P1433

The New England Journal of Medicine

P1476

Integration of antiretroviral therapy with tuberculosis treatment.

@en

P2093

Anushka Naidoo

http://www.w3.org/2001/XMLSchema#string

Gerald Friedland

http://www.w3.org/2001/XMLSchema#string

Gonasagrie Nair

http://www.w3.org/2001/XMLSchema#string

Niraksha Jithoo

http://www.w3.org/2001/XMLSchema#string

Santhanalakshmi Gengiah

http://www.w3.org/2001/XMLSchema#string

P2860

Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy.

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.

Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.

Paradoxical reactions in HIV and pulmonary TB.

Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas?

A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.

P304

1492-1501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1014181

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P50

Quarraisha Karim

Salim Abdool Karim

Kogieleum Naidoo

Tanuja N. Gengiah

Anneke C. Grobler

Nesri Padayatchi

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22010915

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

3233684

http://www.w3.org/2001/XMLSchema#string